165 related articles for article (PubMed ID: 11928271)
1. [Atypical neuroleptics in dementia. Managing behavioral disorders early and efficiently].
MMW Fortschr Med; 2002 Mar; 144(10):60-1. PubMed ID: 11928271
[No Abstract] [Full Text] [Related]
2. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric out-patients].
Kurz A; Delius-Stute H; Rettig K; Schwalen S
MMW Fortschr Med; 2003 Oct; 145 Suppl 3():89-95. PubMed ID: 15490773
[TBL] [Abstract][Full Text] [Related]
3. Risperidone use in Korean patients with Alzheimer's disease: optimal dosage and effect on behavioural and psychological symptoms, cognitive function and activities of daily living.
Yoon JS; Kim JM; Lee H; Shin IS; Choi SK
Hum Psychopharmacol; 2003 Dec; 18(8):627-33. PubMed ID: 14696022
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
[TBL] [Abstract][Full Text] [Related]
5. Nursing home research from industry's perspective.
Brecher M
Int Psychogeriatr; 1996; 8 Suppl 3():367-70. PubMed ID: 9154590
[No Abstract] [Full Text] [Related]
6. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.
Onor ML; Saina M; Trevisiol M; Cristante T; Aguglia E
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):205-9. PubMed ID: 17020789
[TBL] [Abstract][Full Text] [Related]
7. [Changeover to risperidone after treatment with conventional low potency neuroleptics in dementia patients. An observation study during usage].
Stoppe G; Schreiner A; Schmitt AB
Dtsch Med Wochenschr; 2006 Mar; 131(9):423-9. PubMed ID: 16493564
[TBL] [Abstract][Full Text] [Related]
8. Underlying mechanisms of psychosis and aggression in patients with Alzheimer's disease.
Mintzer JE
J Clin Psychiatry; 2001; 62 Suppl 21():23-5. PubMed ID: 11584984
[TBL] [Abstract][Full Text] [Related]
9. Geriatric psychopharmacology. Management of late-life depression and the noncognitive behavioral disturbances of Alzheimer's disease.
Raskind MA
Psychiatr Clin North Am; 1993 Dec; 16(4):815-27. PubMed ID: 7906030
[TBL] [Abstract][Full Text] [Related]
10. A pilot, randomized, open-label trial assessing safety and pharmakokinetic parameters of co-administration of rivastigmine with risperidone in dementia patients with behavioral disturbances.
Weiser M; Rotmensch HH; Korczyn AD; Hartman R; Cicin-Sain A; Anand R;
Int J Geriatr Psychiatry; 2002 Apr; 17(4):343-6. PubMed ID: 11994888
[TBL] [Abstract][Full Text] [Related]
11. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A
Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric outpatients].
Kurz A; Delius-Stute H; Rettig K; Schwalen S
MMW Fortschr Med; 2003 Oct; 145(42):55. PubMed ID: 14655446
[No Abstract] [Full Text] [Related]
13. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of controlled pharmacologic trials.
Schneider LS
Int Psychogeriatr; 1996; 8 Suppl 3():375-9; discussion 381-2. PubMed ID: 9154592
[No Abstract] [Full Text] [Related]
15. Shifting from haloperidol to risperidone for behavioral disturbances in dementia: safety, response predictors, and mood effects.
Lane HY; Chang YC; Su MH; Chiu CC; Huang MC; Chang WH
J Clin Psychopharmacol; 2002 Feb; 22(1):4-10. PubMed ID: 11799336
[TBL] [Abstract][Full Text] [Related]
16. Responsiveness of the quality of life in late-stage dementia scale to psychotropic drug treatment in late-stage dementia.
Martin-Cook K; Hynan LS; Rice-Koch K; Svetlik DA; Weiner MF
Dement Geriatr Cogn Disord; 2005; 19(2-3):82-5. PubMed ID: 15572876
[TBL] [Abstract][Full Text] [Related]
17. [General practice study with atypical neuroleptics. Differences in tolerance].
MMW Fortschr Med; 2002 May; Suppl 2():86. PubMed ID: 12070866
[No Abstract] [Full Text] [Related]
18. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
Paleacu D; Barak Y; Mirecky I; Mazeh D
Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
[TBL] [Abstract][Full Text] [Related]
19. [Facilitating nursing at home and in the nursing home].
Krankenpfl J; 2005; 43(1-3):34-5. PubMed ID: 15912827
[No Abstract] [Full Text] [Related]
20. Risperidone in the treatment of elderly patients with psychosis of Alzheimer's disease and related dementias.
Grossman F; Okamoto A; Turkoz I; Gharabawi G
J Am Geriatr Soc; 2004 May; 52(5):852-3. PubMed ID: 15086685
[No Abstract] [Full Text] [Related]
[Next] [New Search]
